Scientists largely agree that stem cells may hold a key to the treatment, and even cure, of many serious medical conditions. But while the use of adult stem cells is widely accepted, many religious groups and others oppose stem cell research involving the use and destruction of human embryos. At the same time, many scientists say that embryonic stem cell research is necessary to unlock the promise of stem cell therapies since embryonic stem cells can develop into any cell type in the human body.
In late 2007, researchers in the United States and Japan succeeded in reprogramming adult skin cells to act like embryonic stem cells. The new development offers the possibility that the controversy over the use of embryos could end. But many scientists and supporters of embryonic stem cell research caution that this advance has not eliminated the need for embryos, at least for the time being.
Recently, the Pew Forum sat down with Yuval Levin, author of Tyranny of Reason, to discuss the ethical and moral grounds for opposing embryonic stem cell research. Previously, Levin was the executive director of the Presidents Council on Bioethics. Currently, he is the Hertog Fellow at the Ethics and Public Policy Center in Washington, D.C., where he also directs the centers Bioethics and American Democracy program.
A counterargument explaining the case for embryonic stem cell research is made by Jonathan Moreno, a professor at the University of Pennsylvania and a senior fellow at the Center for American Progress in Washington, D.C.
Featuring:Yuval Levin, Hertog Fellow and Director of the Bioethics and American Democracy Program, Ethics and Public Policy Center
Interviewer:David Masci, Senior Research Fellow, Pew Forum on Religion & Public Life
Recently, researchers in the United States and Japan successfully turned human skin cells into cells that behave like embryonic stem cells. There has been some discussion that this advance makes the moral and ethical debate over embryonic stem cells moot. Do you think thats an accurate assessment?
I think its going to take a while for the ethical debate to catch up with the science. The scientific community has reacted very positively to this advancement, which was made in November 2007. There have been many additional scientific studies published on the topic since then, and it appears increasingly likely that the cells produced using skin cells are the equivalent of embryonic stem cells. So I think that, in time, this probably will be the final chapter of this particular debate about embryonic stem cells, but I dont think were at the end of it quite yet.
Do you agree with Professor James Thomson, who led the American research team that made this breakthrough, when he maintains that this advance does not, for the time being, abrogate the need for embryonic stem cell research?
Part of his argument for continuing to use embryonic stem cells was backward-looking to make the point that researchers wouldnt have been able to develop this technique if they hadnt been doing embryonic stem cell research. I think thats true, although in a certain way it actually vindicates the logic of President Bushs stem cell policy, which is to allow some work to be done without creating an incentive for the destruction of further embryos to advance the basic science in these kinds of directions.
Thomson also argued that there will still be a need to use embryos in the future. I think thats also a fair argument in the sense that there are always interesting things to learn from different kinds of experiments, but it doesnt address the ethical issues surrounding the debate. If there were no ethical concerns, then certainly the new development wouldnt mean embryonic research would become totally useless. But given that there are concerns, the case for destroying embryos does become a lot weaker. For some people, myself included, the ethical concerns are matters of principle and dont change with new developments.
But for a lot of people, the stem cell debate has always been a matter of balance. People are aware that there are ethical concerns and that there is enormous scientific promise. Now the debate is: Given the ethical questions at stake, is the scientific promise sufficient to make us put the ethical concerns aside and support the research? I think that balance has changed because of this advance, and having an alternative to embryonic stem cell research that achieves the same result will obviously affect the way people think about the ethics of this issue.
That doesnt mean the scientists no longer have any use for embryonic stem cells or even that they wont have any use for them. But I do think it means that people are going to change the way they reason about the balance between science and ethics because of this advance.
I know that you believe that human embryos have intrinsic worth. Do you believe that they have the same intrinsic worth as a five-year-old child or a 50-year-old man?
The question of intrinsic worth is complicated. I dont think it is right to try to determine an embryos intrinsic worth by debating when human life begins. The question of when life begins is a biological question, and the answer actually is fairly straightforward: The life of an organism begins at conception. The ethical question, however, is not about when a life begins but whether every life is equal, and thats a very different question.
I think that the embryonic stem cell debate is ultimately about the question of human equality. The United States has had one answer to that question written in its birth certificate the Declaration of Independence which states that all men are created equal. I think that examining this principle of human equality provides the right answer to this debate, but it is not a simple answer. Human equality doesnt mean that every person is the same or that every person can even be valued in the same way on every scale. What it means is that our common humanity is something that we all share. And what that means, in turn, is that we cant treat a human being in certain ways that we might non-human beings.
The protection of human life comes first. And to the extent that the debate is about whether it is acceptable to destroy a living human being for the purpose of science even for the purpose of helping other human beings I think that in that sense, the embryo is our equal. That doesnt mean that I would think of an embryo in the same way that I would think of a three-year-old child, but I would reject a technique that uses either of them for scientific experimentation.
So in other words, even though you would grieve the death of a 50-year-old man more than a five-day-old embryo, on at least the most basic level you believe that they both have the same right to life.
Yes, thats right. And right to life derives from human equality. The right to life is, in a way, drawn out of the political vocabulary of the Declaration of Independence. And so, to my mind, the argument at the heart of the embryonic stem cell debate is the argument about human equality.
Recently in The New Republic magazine, Harvard psychologist Steven Pinker wrote that conservative bioethicists like yourself consistently predict the worst when looking at developments in biotechnology. He went on to say that had there been a presidents council on cyber-ethics in the 1960s, no doubt it would have decried the threat of the Internet since it would inexorably lead to 1984 or computers taking over like HAL in 2001. How do you respond to this suggestion that there always seems to be this sort of chorus of doomsayers every time something new comes along?
To my mind, biotechnology is fundamentally different from past developments in technology because its directed to the human person. From the beginning of the scientific revolution, science and technology have tried to allow us to manipulate and shape the world around us for the benefit of man. Now that were beginning to manipulate and shape man, the question is: For the benefit of what? In some cases thats easy to see. Obviously curing disease is more of an old-fashioned scientific pursuit. But there are newer scientific developments, such as certain types of human enhancement technologies that raise very complicated questions of how we should judge the ends and the means of technological advancements. That being said, Pinker has a point, in a larger sense that judging the risks of new technologies is very difficult. In general, I think we ought to give the benefit of the doubt to our ability to use new technologies. I dont think that we should assume that the worst will happen. But there are specific instances, which are few but very important, when we do need to be cautious.
Lets shift gears to a question about religion and faith. Obviously there are people of faith on both sides of this debate. In fact, there are conservatives traditional social conservatives, such as Republican Sen. Orrin Hatch of Utah who support embryonic stem cell research. But could you explain how the Judeo-Christian and Western moral ethic informs your views on this issue and why you think that God is ultimately on your side?
Well, I dont know that I think that. My approach to this is not religious. Im not a particularly religious person and I come at this from more of a liberal democratic concern for human equality and the foundations of our society. That being said, those foundations are not utterly secular, and my understanding of them is not utterly secular. I think that to believe in human equality you do have to have some sense of a transcendent standard by which to make that judgment. In other words, when we talk about equality, what do we mean? Equal in relation to what?
Some people have certainly tried to make a purely secular liberal argument for human equality. While I think its very hard to ground a genuine, deep belief in human equality in a worldview that sees nothing above the material, I dont think that that belief depends on specific theological commitments. To my mind, its an American belief more than it is a religious belief.
Certainly I think that President Bushs commitment to human equality has a lot to do with a particular Christian sense of human worth and human value. But I dont think that its necessary to ground yourself in a particular theological or sectarian preference. I think that this is really about whether we believe in a liberal society, which comes from a belief in human equality. The American left, which for the most part is on the other side of this debate from where I am, has always been the champion of human equality, and I think that its a question that they have to really think about.
The Pew Forum and the Pew Research Center for the People & the Press have done polling on this issue over the last six or seven years and have found that Americans generally favor embryonic stem cell research. Why do you think this has happened, and what do you think this trend indicates?
Thats an interesting question. We actually did a poll here at the Ethics and Public Policy Center in February on a similar question, and the lesson I drew from that, and from some other polling thats been done, is that on the stem cell debate, people are just very confused about the facts, and the trend lines have generally followed the sense that cures are coming. In the end, the issue has been misrepresented as a choice between cures and Christianity, and people increasingly think that curing people like Christopher Reeve is just as much of a human good as protecting an embryo that they cant even imagine.
But when you dig down into peoples views about stem cell research, you find a great deal of confusion, and when you put the questions in ethical terms, you find small majorities opposing it. When you put the question in medical terms, you find, I think, somewhat larger majorities supporting it. In our poll, we asked the same people a series of questions that basically put the same issue in several different ways, and their responses are total opposites of one another. The fact that the same people come out on the opposite sides of the same issue when its put in different ways suggests to me that the issue is very hard to understand which it is.
Frequently one hears that, ultimately, you cant stop science or progress and that ethical, moral and religious objections inevitably will fall by the wayside when there are clear material gains to be made. Do you think thats the most likely scenario in this case, assuming the scientific community continues to see a need for embryonic stem cell research?
Well, thats the big assumption, right? To my mind, the aim of people such as myself has always been to find ways of doing the science without violating the ethics rather than to force a choice between the science and the ethics. If we force that choice, I think its more likely that the country would choose science over ethics, and thats exactly why we have to avoid the choice. I dont think we should be overconfident in our ability to persuade people to pass up a material benefit for an ethical principle, although I hope that can be done in the stem cell research debate. It certainly has been done in some instances when the principle was more evident and more obvious such as imposing limits on human subject research.
Again, the aim from my point of view and from a lot of people on my side of this argument has been to find ways to advance the science without violating the ethics. Thats the logic of President Bushs stem cell policy; thats why people have been pushing for alternatives; thats why theyre encouraging the development of these latest alternatives to avoid the choice, not to force the choice. I think thats the best thing for the country, from everybodys point of view. You dont want a situation where youve got sort of red-state medicine and blue-state medicine and people believe that the treatment their hospital is giving them is obtained in unethical ways. That would begin to break up the practice of medicine and to affect our attitudes about science which on the whole has done a tremendous amount of good for society. So I think what everybody should aim for is finding a way to end this potentially very damaging debate rather than force a choice.
This transcript has been edited for clarity, spelling and grammar.
Read more:
The Case Against Embryonic Stem Cell Research: An ...
- The global gene therapy market is valued at an estimated USD 7.3 billion in 2022 and is projected to reach USD 17.2 billion by 2027, at a CAGR of... - August 3rd, 2022
- T-cell Lymphoma Market worth $2.89 billion by 2030 - Exclusive Report by InsightAce Analytic - PR Newswire UK - July 17th, 2022
- Cataract Treatment Market Trends, Drivers and Growth Projection Up to 2029 Alcon Vision LLC, Essilor, Ziemer Ophthalmic Systems, Bausch Health,... - July 17th, 2022
- Global Hunter Syndrome Treatment Market Analysis to 2026 - Focus on Hematopoietic Stem Cell Transplant (HSCT) and Enzyme Replacement Therapy (ERT) -... - July 17th, 2022
- Religious Groups Official Positions on Stem Cell Research ... - December 8th, 2021
- Regenerative Stem Cells Knee Pain Treatment London, UK ... - December 8th, 2021
- The mTOR Pathway in Pluripotent Stem Cells: Lessons for ... - December 8th, 2021
- Hematopoietic Stem Cell Differentiation Pathways & Lineage ... - December 8th, 2021
- Dutch stem cell biotech Neuroplast secures 10 million ... - December 8th, 2021
- Stem Cell Banking Market Size 2021, Latest Business Opportunities, Growth Statistics, Industry Share, Upcoming Trends, Covid-19 Impact, Demand... - December 8th, 2021
- Removal of sanctions major reason for Iran's signature on JCPOA - Tehran Times - December 8th, 2021
- Primary Cells Market Research Report by Origin, by Cell Type, by End-user, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19 - Yahoo... - August 4th, 2021
- Global Stem Cell Assay Market growth will help industry players with different potential opportunities to explore the market 2021-2027 The Manomet... - August 4th, 2021
- US trade and investment in Africa - Brookings Institution - August 4th, 2021
- Stem Cell Banking Market Analysis Revealing Key Drivers & Growth Trends through 2029: CCBC, CBR, ViaCord, Esperite, Vcanbio, and others. KSU |... - February 14th, 2021
- Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size Is Expected To Generate Huge Profits and Competitive Outlook - The Courier - February 14th, 2021
- Coronavirus Briefing: What Happened Today - The New York Times - February 6th, 2021
- Global Placental Stem Cells (PSCS) Market 2020: Opportunity and Growth Analysis||LifeCell International Pvt. Ltd., StemCyte India Therapeutics Pvt.... - February 6th, 2021
- India Cord Stem Cell Banking Market Witness an Outstanding Growth and Strong Revenue and Forecast to 2026 KSU | The Sentinel Newspaper - KSU | The... - January 23rd, 2021
- Global Placental Stem Cells (PSCS) Market Is Expected To Gain Market Growth In The Forecast Period Of 2020 To 2027||ESPERITE NV, LifeCell... - January 23rd, 2021
- Massive Growth Of Bone Marrow Market Size Strong Revenue and Competitive Outlook KSU | The Sentinel Newspaper - KSU | The Sentinel Newspaper - January 23rd, 2021
- Stem Cell Characterization Kits Market Trends, Forecast, and Analysis by 2018 to 2026 NeighborWebSJ - NeighborWebSJ - January 23rd, 2021
- Stem Cell Therapy Market 2021-2026 Insights on Type, Region and Comprehensive Analysis of the Development Factors in the Industry Reviewindependent -... - January 23rd, 2021
- Doctor: COVID-19 cases will continue to slowly go down, but were not out of the woods - Yahoo Money - January 23rd, 2021
- Global Blood and Organ Bank Market 2021 Overview, Trends, Growth Factors and Leading Players With Detailed Analysis of Industry Structure The Courier... - January 23rd, 2021
- Global Myelodysplastic syndromes (MDS) Market With COVID 19 Impact Analysis| Leading Players In-depth Analysis Research Report Foresight to 2027 KSU... - January 23rd, 2021
- The 11 most mind-blowing, awe-inspiring health discoveries and innovations of 2020 - Business Insider - Business Insider - December 22nd, 2020
- Cultured Protein: A Guide To Every Cell-Based Meat Startup In The World Right Now - Green Queen Media - December 22nd, 2020
- Comprehensive Report on Animal Stem Cell Therapy Market 2021 | Size, Growth, Demand, Opportunities & Forecast To 2027 | ANIMAL CELL THERAPIES,... - December 22nd, 2020
- Comprehensive Report on Cancer Stem Cell Market 2020 | Size, Growth, Demand, Opportunities & Forecast To 2026 | Thermo Fisher Scientific, Inc.,... - December 22nd, 2020
- Report On Smart Sensor Market to 2026: (Industry Insights, Company Overview and Investment Analysis) - Farming Sector - December 22nd, 2020
- Latest Study Explores The IVF Market Update 3 Reasons 2021 Could Be The Year Of Great Turnaround - Farming Sector - December 22nd, 2020
- Global Primary Antibodies Market To Reflect Impressive Growth Rate by 2028||Leading Players-Thermo F - PharmiWeb.com - December 22nd, 2020
- Rapper Trae Tha Truth gives back to homeless after Thanksgiving - Yahoo News - December 22nd, 2020
- Haywards Heath woman's bid to fund stem cell treatment to combat MS - Mid Sussex Times - December 14th, 2020
- Regenerative Medicine: Market Trends and Legal Developments on the Horizon for 2021 - MedTech Intelligence - December 14th, 2020
- Worldwide Stem Cell Therapy Market Insights to 2025 - Analysis and Forecasts - GlobeNewswire - December 4th, 2020
- Impact Of Covid-19 on Stem Cell Assay Market 2020 Industry Challenges, Business Overview and Forecast Research Study 2026 - The Market Feed - December 4th, 2020
- Stem Cells Market is Expected to Thrive at Impressive CAGR by 2025 - The Haitian-Caribbean News Network - December 4th, 2020
- Nobel Prize history from the year you were born - Albany Democrat Herald - December 4th, 2020
- Stem Cell Therapy Market Size, Share, Global Market Research and Industry Forecast Report, 2025 (Includes Business Impact Of Covid-19) - The... - December 4th, 2020
- Stem Cell Assay Market Report 2020 Potential Effect on Upcoming Future Growth by Top Vendors: GE Healthcare, Promega Corporation, Thermo Fisher... - December 4th, 2020
- Transfection Technologies Market Size 2020 | Global Business Strategies, Growing CAGR of 20.0%, Industry Revenue, Opportunities-Aldrich Co Thermo... - December 4th, 2020
- Membrane Filtration Devices Market with COVID-19 Impact, Size 2020, Share, Industry Trends, Future Growth, Regional Overview, Revenue and Forecast... - December 4th, 2020
- Whole Genome Bisulfite Sequencing (WGBS) Market Market To Grow At A CAGR Of 12.90% In The Forecast Period Of 2020 To 2027 | Major Giants Illumina,... - December 4th, 2020
- Global Stem Cell Banking Market to Get Expansion admist COVID 19, Scope With Advanced Technologies Top Key Players and Forecast 2020-2027 - The... - November 28th, 2020
- Scaffold Technology Market Research Report by Product, by Application, by End-User - Global Forecast to 2025 - Cumulative Impact of COVID-19 -... - November 28th, 2020
- Global Cell Therapy Technologies Market 2020 by Manufacturers, Countries, Type and Application, Forecast to 2026 - Cheshire Media - November 28th, 2020
- Global Animal Cell Culture Market Professional Survey 2019 by Manufacturers, Regions, Types and Applications, Forecast to 2027 by Reportspedia -... - November 28th, 2020
- Global Seed Treatment Fungicides Market 2020 Size Share Upcoming Trends Segmentation And Forecast To 2025 - The Courier - November 28th, 2020
- Stem Cell Source Market Technology Advancements and Business Outlook 2020-2026 - PharmiWeb.com - November 19th, 2020
- Comprehensive Report on Stem Cell Assay Market 2020 | Size, Growth, Demand, Opportunities & Forecast To 2026 | Bio-Techne Corporation, Promega... - November 19th, 2020
- Cell Therapy Market 2020-2025 Business Strategies JCR Pharmaceuticals Co., Ltd., Kolon TissueGene, Inc.; and Medipost - The Think Curiouser - November 19th, 2020
- Impact Analysis of Covid-19 On Global Stem Cell Assay Market Continues to Expand to Support Development and Top Players: Merck & Co., Thermo... - November 19th, 2020
- Global Cell Expansion Market Size 2020 | Growth Opportunities, Top Leaders, Revenue, Regional Overview and Forecast to 2027 - PRnews Leader - November 19th, 2020
- Primary Cells Market Research Report by Origin, by Cell Type, by End-user - Global Forecast to 2025 - Cumulative Impact of COVID-19 - GlobeNewswire - November 19th, 2020
- Global Cell and Gene Therapy Market 2020 Key Drivers and Challenges, Opportunities and Forecast Insights by 2025 - KYT24 - November 19th, 2020
- Asset Tracking and Inventory Management Solutions Market outlook by industry size share revenue regions and top key players analysis - The Think... - November 19th, 2020
- DAPT Market to Witness Increase in Revenues by 2020-2028 - The Think Curiouser - November 19th, 2020
- Stem Cell Umbilical Cord Blood Market to Enable the Stakeholders to Capitalize on the Prevailing Industry Opportunities with Investment Analysis By... - October 31st, 2020
- Impact Of Covid 19 On Adult Stem Cells Market 2020 Industry Challenges, Business Overview And Forecast Research Study 2026 - PRnews Leader - October 31st, 2020
- Global Stem Cell Media Market Dynamics Analysis, Production, Supply and Demand, Covered in the Latest Research 2020-2025 - re:Jerusalem - October 31st, 2020
- Comprehensive Report on NK Cell Therapy and Stem Cell Therapy Market 2020 | Size, Growth, Demand, Opportunities & Forecast To 2026 | Chipscreen... - October 31st, 2020
- Mesenchymal Stem Cells Market Augmented Expansion to Be Registered by 2020-2025 - Eurowire - October 31st, 2020
- Global Induced Pluripotent Stem Cells (iPSCs) Market 2020 with COVID-19 After Effects Growth Drivers, Top Key Players, Industry Segments and Forecast... - October 31st, 2020
- Canine Stem Cell Therapy Market Overview, Development by Companies and Comparative Analysis by 2026 - The Think Curiouser - October 31st, 2020
- Global Adipose Derived Stem Cell Therapy Market 2020 Leading Players, Industry Updates, Comprehensive Analysis and Forecast 2025 - re:Jerusalem - October 31st, 2020
- Outlook on the Regenerative Medicine Global Market to 2025 - Impact of COVID-19 on the Market - GlobeNewswire - October 31st, 2020
- Rising Adoption of Cell Therapy Processing Market by 2020-2027 with Major Giants: BioTime, Inc., Regeneus Ltd., Targazyme, Inc., Bone Therapeutics,... - October 31st, 2020
- Cancer Stem Cells (CSCs) Market to Flourish with an Impressive Cagr During 2020-2027 - The Think Curiouser - October 31st, 2020
- Stem Cell Cryopreservation Equipment Market : In-depth Analysis to Understand the Competitive Outlook of the Global Industry with Future Estimations -... - October 31st, 2020
- Biologics Safety Testing Market : Segmentation, Industry Trends and Development to 2026 - Eurowire - October 31st, 2020
- How Humanity Spent Its First 20 Years in Orbit Aboard the ISS - WIRED - October 31st, 2020
- What to Know in Washington: Provisional Ballots May Play Role - Bloomberg Government - October 31st, 2020
- Impact of COVID-19 on Animal Cell Culture Market 2020 | Size, Growth, Demand, Opportunities & Forecast To 2026 | Life Technologies, Thermo Fisher,... - October 31st, 2020
- Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Research Study 2020 Insights with COVID-19 Impact Analysis by 2020Orange... - August 30th, 2020
- Global Cell Isolation Technology Market 2020 Analysis, Types, Applications, Forecast and COVID-19 Impact Analysis 2025 - Scientect - August 30th, 2020
- Suramin Sodium Market Projected to Witness a Single-Digit CAGR During 2019-2025 - StartupNG - August 30th, 2020
- Stem Cell Characterization and Analysis Tool Market Growth, Size, Opportunities and Analysis Forecast 2020 - 3rd Watch News - July 12th, 2020
- Ascending Demand for Transient Protein Expression to Propel the Growth of the Transient Protein Expression Market Between 2020-2030 - Cole of Duty - July 12th, 2020